Literature DB >> 2516508

Probable pseudocholinesterase induction by valproic acid, carbamazepine and phenytoin leading to increased serum aspirin-esterase activity in epileptics.

E Puche1, M Garcia Morillas, H Garcia de la Serrana, C Mota.   

Abstract

The present findings show clearly that valproic acid, carbamazepine and phenytoin are each capable of significantly raising serum aspirin-esterase activity in epileptics being treated with these drugs (between p less than 0.01 and p less than 0.05). The data suggest that these antiepileptic drugs may well act as enzymatic-inducing agents upon plasma cholinesterase (or pseudocholinesterase) in epileptic patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516508

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  5 in total

1.  Prolonged duration of succinylcholine in patients receiving anticonvulsants: evidence for mild up-regulation of acetylcholine receptors?

Authors:  A T Melton; J F Antognini; G A Gronert
Journal:  Can J Anaesth       Date:  1993-10       Impact factor: 5.063

2.  The protective role of parsley extract against vincristine mutagenicity in Drosophila melanogaster.

Authors:  Saleha Y M Alakilli
Journal:  Saudi J Biol Sci       Date:  2010-01       Impact factor: 4.219

3.  A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid.

Authors:  Natalia Lampon; J Carlos Tutor
Journal:  Ups J Med Sci       Date:  2010-12-29       Impact factor: 2.384

4.  Phenytoin toxicity from cocaine adulteration.

Authors:  Carlos J Roldan
Journal:  West J Emerg Med       Date:  2014-03

5.  Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.

Authors:  Lili Mikecin; Miljenko Krizmaric; Jasminka Stepan Giljevic; Miroslav Gjurasin; Josipa Kern; Jasna Lenicek Krleza; Ljiljana Popovic
Journal:  Croat Med J       Date:  2013-10-28       Impact factor: 1.351

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.